Following the announcement that four Center for Medicare and Medicaid Innovation (CMMI or Innovation Center) models will end in 2025, the Centers for Medicare & Medicaid Services (CMS) has begun signaling what's next for the...more
5/20/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Drug Pricing ,
Healthcare Reform ,
Innovation ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Physicians ,
Risk Management ,
Value-Based Care
President Donald Trump on May 12, 2025, issued an executive order (EO) titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" and an accompanying Fact Sheet, "President Donald J. Trump...more
5/15/2025
/ Commerce Clause ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Imports ,
Inflation Reduction Act (IRA) ,
Medicaid ,
Medicare ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Trump Administration ,
U.S. Commerce Department ,
USTR
The Centers for Medicare & Medicaid Services (CMS) on April 11, 2025, issued the proposed fiscal year (FY) 2026 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Acute Care Hospital (LTCH) Rule...more
4/25/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Deregulation ,
Executive Orders ,
Healthcare Facilities ,
Hospitals ,
Inpatient Prospective Payment System (IPPS) ,
Long Term Care Facilities ,
Medicare ,
Proposed Rules ,
Regulatory Requirements ,
Reimbursements ,
Request For Information ,
Rulemaking Process ,
Trump Administration
The Centers for Medicare & Medicaid Services (CMS) released on April 4, 2025, the final rule for contract year (CY) 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit...more
4/14/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
ESRD ,
Final Rules ,
Health Care Providers ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Medicare ,
Medicare Advantage ,
Medicare Part D ,
Prescription Drugs ,
Regulatory Requirements
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
4/3/2025
/ Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Executive Orders ,
Federal Budget ,
Federal Funding ,
Federal Grants ,
Healthcare ,
Involuntary Reduction in Force ,
Legislative Agendas ,
New Legislation ,
Presidential Nominations ,
Regulatory Requirements ,
Senate Confirmation Hearings ,
Trump Administration
The Center for Medicare and Medicaid Innovation (CMMI) has released a statement on plans to unveil a new strategy focused on "improving the health of Americans through disease prevention via evidence-based practices,...more
3/19/2025
/ ACOs ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medicare ,
Trump Administration ,
Value-Based Care
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
3/12/2025
/ Affordable Care Act ,
CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Federal Funding ,
Food and Drug Administration (FDA) ,
General Services Administration (GSA) ,
GRAS ,
Health Care Providers ,
Legislative Agendas ,
Medicare ,
Tariffs
The U.S. Department of Health and Human Services (HHS) on Feb. 28, 2025, issued a policy statement limiting the circumstances under which HHS agencies must publish proposed rules for public comment before the rules are...more
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/26/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Department of Government Efficiency (DOGE) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health ,
Regulatory Agenda ,
Regulatory Requirements ,
Tariffs
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/20/2025
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/13/2025
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Data Privacy ,
Department of Health and Human Services (HHS) ,
Deregulation ,
Executive Orders ,
Federal Funding ,
Health Insurance ,
Healthcare Reform ,
Legislative Agendas ,
Medicare ,
Regulatory Agenda ,
Regulatory Requirements ,
Trump Administration
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/6/2025
/ Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Funding ,
Freeze Order ,
Health Care Providers ,
Healthcare ,
Legislative Agendas ,
New Legislation ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings ,
Tariffs
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
1/23/2025
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Constitutional Challenges ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Health Information Technologies ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
MedPAC ,
New Legislation ,
Public Health ,
Regulatory Agenda ,
SCOTUS ,
Telemedicine ,
Trump Administration
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include ...more
1/17/2025
/ Congressional Committees ,
Congressional Intent ,
Department of Health and Human Services (HHS) ,
Federal Funding ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Legislation ,
Regulatory Agenda ,
Trump Administration
The Centers for Medicare & Medicaid Services (CMS) released the Final Rule implementing the Increasing Organ Transplant Access Model (IOTA Model) on Nov. 26, 2024. This mandatory payment model introduces financial incentives...more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
Holland & Knight's Healthcare & Life Sciences Policy Team regularly provides updates through our weekly Health Dose. This special Health Dose: Post-Election Edition is intended to outline the short- and long-term potential...more
11/12/2024
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Intent ,
Election Results ,
Federal Budget ,
General Elections ,
Health Care Providers ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
NDAA ,
Political Parties ,
Presidential Elections ,
Public Policy
The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule with comment...more
11/7/2024
/ Ambulatory Surgery Centers ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Final Rules ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Hospitals ,
Inpatient Prospective Payment System (IPPS) ,
Medical Devices ,
Medicare ,
Outpatient Prospective Payment System (OPPS) ,
Payment Rates ,
Prescription Drugs ,
Rural Health Care Providers ,
Tribal Government Programs
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
The Centers for Medicare & Medicaid Services (CMS) on Sept. 20, 2024, released the Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434) Final Rule....more
For nearly 40 years and in more than 18,000 judicial opinions, federal courts have used the Chevron doctrine to defer to an agency's reasonable interpretation of an ambiguous statute. On June 28, 2024, the U.S. Supreme Court...more
9/3/2024
/ Administrative Procedure Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Chevron Deference ,
Chevron v NRDC ,
Consumer Financial Protection Bureau (CFPB) ,
Corner Post Inc v Board of Governors of the Federal Reserve System ,
Department of Justice (DOJ) ,
Department of Labor (DOL) ,
Department of Transportation (DOT) ,
Environmental Protection Agency (EPA) ,
Federal Trade Commission (FTC) ,
FERC ,
Food and Drug Administration (FDA) ,
Government Agencies ,
HUD ,
IRS ,
Judicial Authority ,
Loper Bright Enterprises v Raimondo ,
NTSB ,
OCC ,
Popular ,
Regulatory Authority ,
Relentless Inc v US Department of Commerce ,
SCOTUS ,
Stare Decisis ,
Statute of Limitations ,
Statutory Interpretation ,
U.S. Treasury
The Centers for Medicare & Medicaid Services (CMS) issued the final rule for fiscal year (FY) 2025 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) on Aug. 1, 2024....more
The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2025 Revisions to Payment Policies Under the Physician Fee Schedule (MPFS) and Other Revisions to Medicare Part B (CMS-1807-P) Proposed...more
The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Proposed Rule (CMS-1809-P),...more
The U.S. Supreme Court issued a significant ruling on June 28, 2024, that changes the respective roles of administrative agencies and the courts in interpreting statutes. In Loper Bright Enterprises v. Raimondo, the court...more
7/5/2024
/ Administrative Procedure Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Chevron Deference ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Health Care Providers ,
Loper Bright Enterprises v Raimondo ,
OCR ,
Regulatory Authority ,
SCOTUS ,
Statutory Interpretation